Beijing Luther Cage Trading Co., Ltd., established on 1997-02-19, The scope of business includes sales of health food;Sales of teaching instruments,arts and crafts,department store,building materials,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Wujinjiaodian,Computer software and hardware,electrical equipment,auto parts;Real estate information consultation(no intermediary);Technology development of technology products,Technical Training;Labor service(Except for projects that have not obtained special permits).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Wholesales pharmaceutical, medical and orthopaedic products

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

The legal basis for the treatment of the data is the consent granted by the User when providing the data. The data will be kept while the relationship is maintained and its deletion is not requested and in any case in compliance with statutory limitation periods that may be applicable.

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. It operates through the following business segments: Business to Business (BtoB), Business to Consumer (BtoC), and Biomedical. The BtoB segment offers functional materials such as Pharma GABA, Bone Pep, Lampep, HGP, and Pharma Biomix. The BtoC segment provides health food such as Tamagosamin; quasi-drugs such as Pneumo Ikumozai; and cosmetics such as Tamahada no Umitsu and Derma Q II Mild Peeling Gel. The Biomedical segment deals in life science information (LSI) business, which handles the research and development of antibody drugs using ALAgene technology. The company was founded on September 12, 1997 and is headquartered in Kyoto, Japan.

Autobio Diagnostics is a company mainly engaged in development, manufacture and sales of diagnostics products.

ORPEGEN Pharma Gesellschaft fuer biotechnologische Forschung, Entwicklung und Produktion m.b.H. engages in the manufacture of active biopharmaceutical ingredients (bio APIs) such as proteins and peptides. The company was founded on October 28, 1992 and is headquartered in Heidelberg, Germany.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Shanghai Steinway Biotechnology Co., Ltd., established on 2005-05-24, Business scope includes biological products,Research and development of Chinese herbal medicine and Chinese patent medicine,Drug intermediate,Chemical raw materials and products(In addition to dangerous goods)sales and four technical services in related fields(involving administrative licensing,The operating permit).

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA. The company develops drugs that are based on Messenger RNA (mRNA) as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. mRNA programs include novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases (RNActive), molecular therapies designed to trigger the body’s own production of therapeutic proteins (RNArt), and RNA encoded antibodies (RNAntibody). Its most advanced product candidate, CV9104, is being developed in Phase IIb for the treatment of prostate cancer.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Mendes SA is a private company headquartered in Neuilly-sur-Marne, France, that provides general brickwork and major building services. The firm was founded in 1992. Jos�� Mend��s is the CEO, in this role since 2010.

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Shanghai Shengyuan Gene Development Co., Ltd., established on 1998-03-18, Business scope includes bioengineering,Technology transfer in the field of genetic engineering,to develop,consult,Production, supply and marketing of services and related reagents and equipment,.

Suzhou Sitanwei Biotechnology Co., Ltd .was established in May 2007 in Suzhou Biomedical Industrial Park (Suzhou-bioBAY) with world-class software and hardware facilities . The company's aim is to use biomedical theory as the basis for recombinant genes. Based on cell culture and protein engineering technology, they are committed to the research and development of new genetically engineered monoclonal antibodies with global intellectual property rights. The company has received a new venture, Suzhou Tong Xiang venture, Oriental Wealth, with the China Hi-Tech and many other organizations and individuals to invest , in 2008 by the Suzhou Municipal Science and Technology Bureau issued a "domestic R & D institutions," the title , the company several major The founders were awarded the Ph.D. in molecular oncology and immunology at Cornell University School of Medicine, New York University School of Medicine.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Global Cell Holdings (Guangzhou) Co., Ltd., established on 2021-04-28, Business scope includes medical research and experimental development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of hygiene products and single-use medical products;Cosmetics Wholesale;Cosmetics Retail;Remote Health Management Services;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services);General machinery and equipment installation services;Security Consulting Services;